What GLP-1 Drugs Do GLP-1 receptor agonists work by mimicking the glucagon-like peptide-1 hormone, which regulates blood sugar, increases the feeling of fullness, and slows stomach emptying resulting in weight loss and improved glucose control
For semaglutide, the relevant secondary patents include: Formulation patents covering the specific inactive ingredients, pH buffers, and stabilizers that keep semaglutide stable in solution (US 9,714,283, expires 2033) Method-of-use patents covering specific dosing schedules and titration protocols (US 10,195,214, expires 2032) Delivery device patents for the pen injector mechanism used in Ozempic and Wegovy (separate patent family, expires 2029-2031) Oral formulation patents for the SNAC (salcaprozate sodium) absorption enhancer used in Rybelsus tablets (US 9,931,349, expires 2032) The expiration date that matters to you depends on which formulation you care about
The risk is limited track record
If a consumer completes a consultation and is medically disqualified from all treatment options, the company states they are eligible for a full refund of the membership fee